AAA to hear biotech claim against Japanese drugmaker
A US biotech company has filed a claim with the American Arbitration Association against Daiichi Sankyo over the ownership of technology the Japanese group is using in a drug candidate to treat breast cancer.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.